Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $56.28 USD
Change Today -1.27 / -2.21%
Volume 506.6K
PCRX On Other Exchanges
As of 5:20 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James S. Scibetta

Chief Financial Officer, Head of Technical Operations and Senior Vice President,Pacira Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. James S. Scibetta, also known as Jim, has been the Chief Financial Officer of Pacira Pharmaceuticals, Inc. since August 2008 and has been its Senior Vice President since 2014. Mr. Scibetta has been Head of Technical Operations at Pacira Pharmaceuticals, Inc. since January 2015. He served as Secretary of Pacira Pharmaceuticals, Inc. Mr. Scibetta has 13 years of experience in investment banking having worked on Wall Street. He served as the Chief Financial Officer ...

Read Full Background

Corporate Headquarters*

5 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-254-3560
Fax: --

Board Members Memberships*

Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Governance & Nominating Committee


University of Michigan
Wake Forest University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$534,253

Stock Options*

All Other Compensation$966
Exercised Options45,000
Exercised Options Value$3,855,297
Exercisable Options209,002
Exercisable Options Value$17,125,948
Unexercisable Options126,249
Unexercisable Options Value$4,915,185
Total Value of Options$25,896,429
Total Number of Options380,251

Total Compensation*

Total Annual Cash Compensation$535,219
Total Short Term Compensation$534,253
Other Long Term Compensation$966
Total Calculated Compensation$3,515,318
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PCRX:US $56.28 USD -1.27


Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
Rajat Rai Chief Executive Officer
Akorn, Inc.
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
Robert E. Abernathy Chairman, Chief Executive Officer, President and Member of Executive Committee
Halyard Health, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACIRA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at